Vanliga Läkemedel verksamma mot Bukspottkörtelcancer

CARE ONCOLOGY CLINICS PROTOKOLL:

Metformin:

”How diabetes drug metformin inhibits progression of pancreatic cancer”

Doxycyline:

”Doxycycline Induces Apoptosis in PANC-1 Pancreatic Cancer Cells”

 Mebendazole:

“Repositioning approved drugs for the treatment of problematic cancers using a screening approach”

Statiner:

“Statins & Metformin Help Pancreatic Cancer Patients”

”STATINS ASSOCIATED WITH 56% REDUCTION OF PANCREATIC CANCER RISK IN MEN”

”Statin Use and Its Impact on Survival in Pancreatic Cancer Patients”

ANDRA LÄKEMEDEL/TILLSKOTT:

Propranolol:

”β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1”

Disulfiram (Antabus):

”Ny studie: Antabus effektivt mot cancer”

”Investigating the use of Disulfiram, a drug for alcohol abstinence, as a treatment for pancreatic cancer”

Atorvastatin, Celecoxib, Tipifarnib:

”A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.”

Diclofenac:

”Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity”

Curcumin:

“Phase II trial of curcumin in patients with advanced pancreatic cancer”

Vitamin A:

“Vitamin A may help improve pancreatic cancer chemotherapy”

Artesunate:

“Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo.”

Hydroxychloroquine:

“Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer”

Dipyridamole:

“Prevention of human pancreatic cancer cell-induced hepatic metastasis in nude mice by dipyridamole and its analog RA-233.”

FALLSTUDIE:

Fyra ukspottskörtelcancerpatienter som svarat extremt väl på behandling med ALA och Naltrexon presenteras i följande två fallstudier:

“The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.

“Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases

Livmoderhalscancer

”Repurposed” läkemedel relevanta vid livmoderhalscancer:

Professorn som botade sin hjärntumör med en cocktail av ‘vanliga’ mediciner

När den då 50-åriga psykologiprofessorn drabbades av en aggressiv hjärntumör, stor som en apelsin, så började han själv att undersöka alternativa behandlingar. 20 år senare har tumören inte återvänt.

Av dessa tog Professor Williams följande

  • Metformin Diabetsläkemedel
  • Statiner Kolesterolsänkande läkemedel
  • Mebendazole: Behandlar parasitmaskar
  • Cimetidin: Magsårsmedicin
  • Itrakonazol: Behandlar svampinfektioner
  • Isotretinoin: Akne läkemedel

Professor Williams leder även ett initiativ kallat Anti Cancer Alliance.

Anti-cancer Alliance –> ‘Paper’:

Co-ordinated Undermining of Survival Pathways of Glioblastoma for the Newly Diagnosed (CUSP-ND)

  • Auranofin
  • Agomelatine
  • Celecoxib
  • Chloroquine
  • Cimetidine
  • Curcumin
  • Disulfiram
  • Fluoxetine
  • Itraconazole
  • Levetiracetam (Keppra)
  • Mebendazole
  • Metformin
  • Minocycline
  • Polysaccharide Krestin
  • Telmisartan
  • Valproic Acid / Sodium Valproate

Länk till ursprungsartikel

Sammanställning av Ben Williams ”cocktail”.

En forum där ”cocktails” för hjärntumörer diskuteras är: our brain tumor cocktails and stories